Nuova versione aggiornata della fiala di vetro nel

Data: 26 novembre 2012
Nuova versione aggiornata della fiala di vetro nel confezionamento
dell’impianto
In occasione del rilascio degli impianti Neoss Tapered di diametro 5,5, è stata introdotta una
versione aggiornata della fiala di vetro contenente l’impianto . A partire da ottobre con
l’impianto Tapered ø5.5, il nuovo tappo di chiusura della fiala verrà progressivamente
introdotto su tutta la gamma di impianti Neoss tra l’autunno e l’inverno. Il nuovo design
“premi e apri” permette:
•
•
•
•
una rimozione più facile e veloce del tappo
una completa visibilità dell’impianto
una posizione dell'impianto che consente un aggancio facilitato
il medesimo confezionamento per tutte le dimensioni implantari
Il materiale di confezionamento, estremamente apprezzato, rimane il vetro; rimangono
inoltre invariate le caratteristiche e prestazioni della superficie ultrapulita dell’impianto. La
versione aggiornata della fiala di vetro contenente l’impianto è pienamente compatibile
con gli Organizzatori clinici Neoss.
Neoss Italia S.r.l.
Via Marco Antonio
Colonna, 42
I-20149 Milano
Italia
t
f
+39 02.92952
+39 02.92952.250
e [email protected]
w www.neossitalia.it
Neoss Ltd ⋅ Registered Office: Floor 3, Windsor House, Cornwall Road, Harrogate, HG1 2PW, United Kingdom
Registered in England & Wales No: 04120053 ⋅ VAT No. GB 817 3629 18
st
Winner Yorkshire Insider International Healthcare Trade Awards 2012, 1 in the Insider Yorkshire Growth
100
2012,
NEOSS CONTACT:
Alessandra Negroni
Marketing & Activities Manager
[email protected]
Tel. +39 02.92952.220
NOTES FOR EDITORS:
Neoss’ objective is to advance the science of dental implant treatment and build a significant and profitable
dental implant company recognised for leading innovation, customer focus and ethical principles.
Dental implants are titanium screws that are used to anchor a single dental crown or a number of artificial teeth
as a bridge or a denture. They act as alternatives to traditional crowns, bridges, dentures and false teeth. The
largest markets are Europe and the US which represent 48% and 24% of the global market. It is a highly
attractive market with leading companies achieving gross margins in excess of 80%. The Neoss dental implant
system is the most efficient dental implant system in the market. It combines market-leading functionality for
the patient with the lowest level of complexity available for the Surgeon. In essence the system does more
things, more simply and more economically than the current market leaders, and it does all those things at least
as well if not better than its competitors.
Recent product launches include:
Neoss Tapered implant launched in 2012, incorporates the full benefits of the Neoss ProActive® surface. The
combination of the tapered body and thread cutting and forming design provides extremely good seating in
compromised or dense bone, and it apical profile aids placement in soft bone. The Neoss Tapered and Neoss
ProActive® implants have a single abutment connection (excluding Ø3.25) providing great prosthetic freedom
and a surgical kit with minimal components. Esthetiline – the complete anatomical restorative solution. Dental implant aesthetics and crowns have become
increasingly refined in recent years. Launched in 2011, the Neoss Esthetiline Solution is the first to provide
seamless restorative integration all the way through from implant placement to final crown restoration.
Neoss ProActive® implant, launched 2009, an implant building on the proven design of the Neoss Bimodal
Implant, is a Hydrophilic implant. The implant surface enhances protein aggregation and can accelerate fibrin
network formation. Studies show the, patent pending, etched and blasted ProActive implant surface stimulates
bone to form more rapidly and with a greater strength at the implant interface.
The Company founded in 2000 by Doctor Neil Meredith and CTO, Fredrik Engman is head quartered in the
Harrogate, in the United Kingdom and has operations in USA, Germany, Austria, Italy, Sweden, Australia and
New Zealand and is represented in Switzerland, Ireland, Croatia, Poland, Turkey, Japan, Thailand and Taiwan by
exclusive distributors.
Neoss main investors are MMC Ventures, Delta Partners, Brian Souter Investments and Medtronic Inc.
Further information is available at www.neoss.com